Andrew Jarratt

1 article listing Andrew Jarratt in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial Nature Communications